UBS Group’s Amplify Seymour Cannabis ETF CNBS Stock Holding History
Bought
Maintained
Sold
Other funds holding CNBS
TI
MFG
FLP
UBS Group's CNBS Position: Q1 2026 in Review
UBS Group increased its Amplify Seymour Cannabis ETF (CNBS) stake by 793% in Q1 2026, buying an estimated $15.8K and bringing the position to 714 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #8104.
UBS Group first reported a position in CNBS in Q1 2020 and has held it in 16 quarters since. The position peaked at $149K in Q3 2025. 20 funds tracked by Wall St. Rank hold CNBS as of Q1 2026.
- UBS Group held 714 shares of Amplify Seymour Cannabis ETF worth $15.7K as of Q1 2026.
- UBS Group bought 634 Amplify Seymour Cannabis ETF shares in Q1 2026, an estimated $15.8K.
- Amplify Seymour Cannabis ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8104 holding.
- UBS Group first reported a position in Amplify Seymour Cannabis ETF in Q1 2020 and has held it in 16 quarters since.
- UBS Group's Amplify Seymour Cannabis ETF position peaked at $149K in Q3 2025.
- 20 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.